The study will include the recruitment of 1,020 participants from 10 gastroenterology departments of hospitals in Shanghai and Beijing. In the study, participants will be divided into three groups — erosive reflux disease, non-erosive reflux disease and control.
The study will examine the sensitivity in each of these groups and the efficacy of Peptest for diagnosing reflux.
More articles on GI/endoscopy:
Dr. Amar Naik joins Loyola University Health System
AGA to hold workshop on effective scope cleaning
15 gastroenterologist CEOs
